1 ANORO ELLIPTA (UMECLIDINIUM BRM/VILANTEROL TR) | 10 of 4570 | 8890 prescriptions Less than 1% of all prescriptions | 8730 | 1360 patients 20% of all patients | < 11 | |
2 SYMBICORT (BUDESONIDE/FORMOTEROL FUMARATE) | 30 of 5720 | 6610 prescriptions Less than 1% of all prescriptions | 6220 | 1320 patients 19% of all patients | < 11 | |
3 VENTOLIN HFA (ALBUTEROL SULFATE) | 100 of 5820 | 6150 prescriptions Less than 1% of all prescriptions | 5870 | 1900 patients 27% of all patients | < 11 | |
4 PROAIR HFA (ALBUTEROL SULFATE) | 60 of 5330 | 6330 prescriptions Less than 1% of all prescriptions | 6060 | 2100 patients 30% of all patients | < 11 | |
5 INCRUSE ELLIPTA (UMECLIDINIUM BROMIDE) | 70 of 4930 | 4250 prescriptions Less than 1% of all prescriptions | 4030 | 820 patients 12% of all patients | < 11 | |
6 ARNUITY ELLIPTA (FLUTICASONE FUROATE) | 10 of 1840 | 3300 prescriptions Less than 1% of all prescriptions | | 710 patients 10% of all patients | < 11 | |
7 MONTELUKAST SODIUM | 480 of 5230 | 3060 prescriptions Less than 1% of all prescriptions | 2790 | 660 patients 10% of all patients | < 11 | |
8 ADVAIR DISKUS (FLUTICASONE PROPION/SALMETEROL) | 240 of 5490 | 2980 prescriptions Less than 1% of all prescriptions | | 600 patients 9% of all patients | < 11 | |
9 BREO ELLIPTA (FLUTICASONE/VILANTEROL) | 730 of 4880 | 1990 prescriptions Less than 1% of all prescriptions | 1850 | 550 patients 8% of all patients | < 11 | |
10 STIOLTO RESPIMAT (TIOTROPIUM BR/OLODATEROL HCL) | 20 of 1870 | 1950 prescriptions Less than 1% of all prescriptions | 1950 | 250 patients 4% of all patients | 250 patients 4% of all patients | |
11 SPIRIVA (TIOTROPIUM BROMIDE) | 480 of 5050 | 1650 prescriptions Less than 1% of all prescriptions | 1650 | 310 patients 4% of all patients | 310 patients 4% of all patients | |
12 SPIRIVA RESPIMAT (TIOTROPIUM BROMIDE) | 340 of 3750 | 1360 prescriptions Less than 1% of all prescriptions | 1360 | 200 patients 3% of all patients | 200 patients 3% of all patients | |
13 RIFAMPIN | 30 of 420 | 1070 prescriptions Less than 1% of all prescriptions | 1070 | 190 patients 3% of all patients | 190 patients 3% of all patients | |
14 AZELASTINE HCL | 190 of 1680 | 760 prescriptions Less than 1% of all prescriptions | | 250 patients 4% of all patients | < 11 | |
15 FLUTICASONE PROPIONATE | 870 of 4500 | 590 prescriptions Less than 1% of all prescriptions | | 380 patients 5% of all patients | < 11 | |
16 COMBIVENT RESPIMAT (IPRATROPIUM/ALBUTEROL SULFATE) | 200 of 1950 | 780 prescriptions Less than 1% of all prescriptions | | 310 patients 4% of all patients | < 11 | |
17 ETHAMBUTOL HCL | 40 of 480 | 750 prescriptions Less than 1% of all prescriptions | 750 | 180 patients 3% of all patients | 180 patients 3% of all patients | |
18 BEVESPI AEROSPHERE (GLYCOPYRROLATE/FORMOTEROL FUM) | 50 of 910 | 710 prescriptions Less than 1% of all prescriptions | 710 | 110 patients 2% of all patients | 110 patients 2% of all patients | |
19 DALIRESP (ROFLUMILAST) | 160 of 1740 | 680 prescriptions Less than 1% of all prescriptions | 680 | < 11 | < 11 | |
20 FLOVENT DISKUS (FLUTICASONE PROPIONATE) | 60 of 840 | 700 prescriptions Less than 1% of all prescriptions | 700 | 140 patients 2% of all patients | 140 patients 2% of all patients | |
21 ISONIAZID | 50 of 110 | 570 prescriptions Less than 1% of all prescriptions | 570 | < 11 | < 11 | |
22 PREDNISONE | 1480 of 5580 | 910 prescriptions Less than 1% of all prescriptions | | 640 patients 9% of all patients | < 11 | |
23 AZITHROMYCIN | 500 of 4410 | 1020 prescriptions Less than 1% of all prescriptions | | 690 patients 10% of all patients | < 11 | A |
24 OMEPRAZOLE | 870 of 3040 | 330 prescriptions Less than 1% of all prescriptions | 330 | 160 patients 2% of all patients | 160 patients 2% of all patients | |
25 AMLODIPINE BESYLATE | 830 of 1630 | 300 prescriptions Less than 1% of all prescriptions | | < 11 | < 11 | |
26 FLOVENT HFA (FLUTICASONE PROPIONATE) | 800 of 3090 | 250 prescriptions Less than 1% of all prescriptions | 250 | < 11 | < 11 | |
27 PROAIR RESPICLICK (ALBUTEROL SULFATE) | 120 of 560 | 310 prescriptions Less than 1% of all prescriptions | 310 | 110 patients 2% of all patients | 110 patients 2% of all patients | |
28 OLOPATADINE HCL | 50 of 180 | 250 prescriptions Less than 1% of all prescriptions | 250 | < 11 | < 11 | |
29 ADVAIR HFA (FLUTICASONE PROPION/SALMETEROL) | 510 of 1920 | 240 prescriptions Less than 1% of all prescriptions | 240 | < 11 | < 11 | |
30 TUDORZA PRESSAIR (ACLIDINIUM BROMIDE) | 340 of 1150 | 200 prescriptions Less than 1% of all prescriptions | 200 | < 11 | < 11 | |
31 GABAPENTIN | 510 of 1140 | 190 prescriptions Less than 1% of all prescriptions | | < 11 | < 11 | |
32 CLARITHROMYCIN | 60 of 220 | 190 prescriptions Less than 1% of all prescriptions | 190 | < 11 | < 11 | A |
33 RANITIDINE HCL | 490 of 1170 | 150 prescriptions Less than 1% of all prescriptions | 150 | < 11 | < 11 | |
34 LOSARTAN POTASSIUM | 680 of 1250 | 140 prescriptions Less than 1% of all prescriptions | 140 | < 11 | < 11 | |
35 POTASSIUM CHLORIDE | 420 of 960 | 130 prescriptions Less than 1% of all prescriptions | 00 | < 11 | 00 patients Less than 1% of all patients | |
36 PYRAZINAMIDE | 20 of 30 | 130 prescriptions Less than 1% of all prescriptions | 130 | < 11 | < 11 | |
37 MOMETASONE FUROATE | 260 of 780 | 110 prescriptions Less than 1% of all prescriptions | | < 11 | < 11 | |
38 PROMETHAZINE HCL | 110 of 140 | 120 prescriptions Less than 1% of all prescriptions | 120 | < 11 | < 11 | |
39 AMOXICILLIN-CLAVULANATE POTASS (AMOXICILLIN/POTASSIUM CLAV) | 440 of 1890 | 220 prescriptions Less than 1% of all prescriptions | 220 | 220 patients 3% of all patients | 220 patients 3% of all patients | A |
40 CEFDINIR | 110 of 290 | 210 prescriptions Less than 1% of all prescriptions | 210 | 210 patients 3% of all patients | 210 patients 3% of all patients | A |
41 LEVOFLOXACIN | 540 of 2230 | 190 prescriptions Less than 1% of all prescriptions | 190 | 170 patients 2% of all patients | 170 patients 2% of all patients | A |
42 AMOXICILLIN | 80 of 280 | 190 prescriptions Less than 1% of all prescriptions | | 180 patients 3% of all patients | < 11 | A |